1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A validated whole-blood RNA transcript-based prognostic model that predicts survival in men with castration-resistant prostate cancer
    Meeting Abstract

    Oh, W. K.; Kantoff, P.; Scher, H. I.; Magidson, J.; Wassmann, K.; Lee, G. S. M.; Katz, L. M.; Subudhi, S. K.; Anand, A.; Fleisher, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Characteristics of NSCLCs harboring NRAS mutations
    Meeting Abstract

    Ohashi, K.; Sequist, L. V.; Sos, M.; Chen, X.; Rudin, C. M.; Moran, T.; Arcila, M. E.; Lovly, C. M.; Vnencak-Jones, C. L.; Sasaki, H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase III trial of dovitinib (TKI258) versus sorafenib in patients with metastatic renal cell carcinoma after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor) therapies
    Meeting Abstract

    Motzer, R. J.; Porta, C.; Bjarnason, G. A.; Szcylik, C.; Rha, S. Y.; Esteban, E.; De Giorgi, U.; MacKenzie, M. J.; Mainwaring, P. N.; North, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Post-prostatectomy PSA slope (ProsVue) in Gleason score >= 7 disease
    Meeting Abstract

    Moul, J. W.; Lilja, H.; Semmes, O. J.; Vessella, R.; McDermed, J. E.; Sarno, M. J.; Klem, R. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics, and antitumor activity of MEDI3617, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors
    Meeting Abstract

    Natale, R. B.; Rizvi, N. A.; Infante, J. R.; Joseph, L. J.; Viner, J.; McDevitt, J. T.; Ji, F.; Shin, S.; Liang, M.; Burris, H. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a phase III randomized, open-label, multicenter trial
    Meeting Abstract

    Motzer, R. J.; Nosov, D.; Eisen, T.; Bondarenko, I. N.; Lesovoy, V.; Lipatov, O. N.; Tomczak, P.; Lyulko, A. A.; Alyasova, A.; Harza, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Results from a phase Ib study of trastuzumab emtansine (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab
    Meeting Abstract

    Modi, S.; Elias, A. D.; LoRusso, P.; Samant, M.; Guardino, E.; Althaus, B.; Krop, I. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Treatment of refractory metastatic renal cell carcinoma (RCC) with lenvatinib (E7080) and everolimus
    Meeting Abstract

    Molina, A. M.; Motzer, R. J.; Hutson, T. E.; Larkin, J. M. G.; Gold, A.; Andresen, C.; Wood, K.; Michaelson, M. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I/IIa study of the safety and efficacy of radium-223 chloride (Ra-223) with docetaxel (D) for castration-resistant prostate cancer (CRPC) patients with bone metastases
    Meeting Abstract

    Morris, M. J.; Hammers, H. J.; Sweeney, C.; Bloma, M.; Aksnes, A. K.; O'Bryan-Tear, C. G.; Carrasquillo, J. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save